Skip to content
Press Release
FEATURED | January 24, 2025

The Melanoma Research Foundation Announces Rebrand...

Washington, DC (January 27, 2025) – The Melanoma Research Foundation (MRF), the largest independent organization devoted to melanoma, is excited to announce the official ...

3 Minute Read
December 20, 2021

Melanoma Risks and Risk Prediction in Patients wit...

Actinic keratoses are common pre-cancerous skin lesions that can transform into cutaneous squamous cell carcinoma and whose presence may also be associated with increased r...

3 Minute Read
December 20, 2020

CXCL9 as an Immune Anti-Melanoma Therapy in Combin...

A major obstacle to even the best melanoma therapies is that in the majority of cases, the tumor never completely goes away. Even if a little bit remains, called the minima...

2 Minute Read
December 20, 2020

Identification of Metastatic Modulators through Ze...

Melanomas arise from pigmented cells called melanocytes, typically in the skin. Melanomas can spread to distal parts of the body, through a process called metastasis. Metas...

3 Minute Read
December 20, 2020

Elucidating Metabolic Changes that Occur in Melano...

Melanoma is the third most common malignancy to metastasize to the brain. It is estimated that at least 50% of patients with stage IV melanoma will develop brain metastases...

2 Minute Read
December 20, 2019

Therapeutic Strategies to Induce Dormancy in Disse...

Metastasis is the main cause of melanoma death. Current treatments mostly fail to cure metastasis. It is of common knowledge that disseminated cancer cells (DCCs) are the...

2 Minute Read
December 20, 2019

Role of PRAME in Epigenetic Reprogramming and Chro...

UM has a propensity to undergo early micrometastasis prior to treatment of the primary tumor, with later emergence of overt metastatic disease. Unfortunately, there has b...

2 Minute Read
December 20, 2019

Augmenting Melanoma Response to Immunotherapy via ...

Cancer immunotherapy (CI) drugs activate our own immune system to directly kill cancer cells. These drugs have revolutionized how we treat many cancers including melanoma....

2 Minute Read
December 23, 2018

Targeting KDM5 Histone Demethylases to Boost Immun...

Description: The goal of this research is to target KDM5s family proteins to enhance the response to immune checkpoint inhibition in melanoma. The recently developed immune...

1 Minute Read
December 20, 2018

Targeting HDAC8 to Overcome the Acquisition of Dru...

There has been great progress in increasing the treatment options for patients who have the skin cancer melanoma in the past decade. However, the melanoma will mo...

2 Minute Read
December 20, 2018

Using the ESC-GEMM Approach to Study Mucosal Melan...

Mucosal melanoma presents a significant challenge for oncologists. Compared to cutaneous melanoma, mucosal melanoma has a far lower survival rate and is more difficult to t...

2 Minute Read
December 20, 2018

Network Rewiring in Melanoma Due to Transcription ...

The cancer genomics field has focused on how mutations in the genome change proteins to cause cells to progress into metastatic cancers. However, new molecular profiling te...

1 Minute Read

Apr 26, 2025 - Apr 27, 2025

Eyes on a Cure: Ocular Melanoma Patient & Caregiver Symposium

May 03, 2025

Miles for Melanoma Washington, DC

May 03, 2025

Mela-No-More Golf Tournament

May 10, 2025

Miles for Melanoma New England, MA

May 10, 2025

Stay Out of the Sun Run

May 10, 2025

The Ohio State University Patient and Caregiver Symposium

May 17, 2025

Melanoma Clinic Walk

Explore Events